Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine mitigates cognitive decline in an Alzheimer’s Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance
Ying Chen, Yu‐Ling Chen, Yubin Liang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109670-109670
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Role of natural products for the treatment of Alzheimer's disease
Tayebeh Noori, Ahmad Reza Dehpour, Antoni Sureda, et al.
European Journal of Pharmacology (2021) Vol. 898, pp. 173974-173974
Closed Access | Times Cited: 121
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
Wei Zhang, Chengchao Xu, Jichao Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 3, pp. 1019-1040
Open Access | Times Cited: 113
Signal pathways in the treatment of Alzheimer’s disease with traditional Chinese medicine
Min-Rui Ding, Yan-Jie Qu, Bing Hu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113208-113208
Open Access | Times Cited: 89
Enhancing autophagy in Alzheimer's disease through drug repositioning
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108171-108171
Closed Access | Times Cited: 71
Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice
Xinlu Li, Jianfeng Chen, Wennuo Feng, et al.
Phytomedicine (2023) Vol. 118, pp. 154962-154962
Closed Access | Times Cited: 53
Advancing green extraction of bioactive compounds using deep eutectic solvent-based ultrasound-assisted matrix solid-phase dispersion: Application to UHPLC-PAD analysis of alkaloids and organic acids in Coptidis rhizoma
Min Han, Kunze Du, Xicheng He, et al.
Talanta (2024) Vol. 274, pp. 125983-125983
Closed Access | Times Cited: 21
Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer’s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis
Samar R. Saleh, Aml Abd-Elmegied, Somaya Aly Madhy, et al.
International Journal of Pharmaceutics (2024) Vol. 658, pp. 124218-124218
Closed Access | Times Cited: 19
Advancements in autophagy perturbations in Alzheimer’s disease: Molecular aspects and therapeutics
Rishika Dhapola, Sneha Kumari, Prajjwal Sharma, et al.
Brain Research (2025) Vol. 1851, pp. 149494-149494
Closed Access | Times Cited: 3
Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease
Zhuo Qu, Jiachen Sun, Wannian Zhang, et al.
Free Radical Biology and Medicine (2020) Vol. 159, pp. 87-102
Closed Access | Times Cited: 104
Natural Compounds and Autophagy: Allies Against Neurodegeneration
Alessandra Stacchiotti, Giovanni Corsetti
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 77
Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation
Anurag Kumar Singh, Saumitra Sen Singh, Aaina Singh Rathore, et al.
ACS Biomaterials Science & Engineering (2021) Vol. 7, Iss. 8, pp. 3737-3753
Closed Access | Times Cited: 66
Berberine: A Promising Treatment for Neurodegenerative Diseases
Ziqian Cheng, Chenglan Kang, Songtian Che, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway
Wangli Ding, Qiuchen Gu, Manman Liu, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110047-110047
Open Access | Times Cited: 32
The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo
Jia-hua Feng, Kang Chen, Siyu Shen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115511-115511
Open Access | Times Cited: 28
Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer’s Disease
Rudolf Vrabec, Gerald Blunden, Lucie Cahlíková
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4399-4399
Open Access | Times Cited: 26
Berberine alleviates Alzheimer's disease by regulating the gut microenvironment, restoring the gut barrier and brain-gut axis balance
Chunbin Sun, Shan‐Shan Dong, Weiwei Chen, et al.
Phytomedicine (2024) Vol. 129, pp. 155624-155624
Closed Access | Times Cited: 15
Jiao-tai-wan and its effective component-berberine improve diabetes and depressive disorder through the cAMP/PKA/CREB signaling pathway
Yueheng Tang, Yang Gao, Kexin Nie, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117829-117829
Open Access | Times Cited: 13
Biologically active isoquinoline alkaloids covering 2019–2022
Dengtuo Wang, Lulu Qin, Chen-Xin Jing, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107252-107252
Open Access | Times Cited: 11
The potential therapeutic role of berberine in treating epilepsy focusing on temporal lobe epilepsy: State of art and ongoing perspective
Bshra A. Alsfouk, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
Brain Research Bulletin (2025) Vol. 221, pp. 111189-111189
Open Access | Times Cited: 1
The Potential Role of Phytochemicals in Alzheimer’s Disease
Ewa Baranowska‐Wójcik, Dorota Gajowniczek-Ałasa, Bożena Pawlikowska-Pawlęga, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 653-653
Open Access | Times Cited: 1
Heavy metal-induced disruption of the autophagy-lysosomal pathway: implications for aging and neurodegenerative disorders
Suman Das, Lokesh Murumulla, Pritha Ghosh, et al.
BioMetals (2025)
Closed Access | Times Cited: 1
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)
Yanyan Kong, Fushuai Wang, Jiao Wang, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 61
Berberine attenuates Aβ42-induced neuronal damage through regulating circHDAC9/miR-142-5p axis in human neuronal cells
Nan Zhang, Yiwen Gao, Shaoli Yu, et al.
Life Sciences (2020) Vol. 252, pp. 117637-117637
Closed Access | Times Cited: 59
Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer’s Disease
Md. Ataur Rahman, Md Saidur Rahman, MD. Hasanur Rahman, et al.
Biomedicines (2020) Vol. 9, Iss. 1, pp. 5-5
Open Access | Times Cited: 55
Non-polyphenolic natural inhibitors of amyloid aggregation
Liang Ma, Chen Yang, Jiaojiao Zheng, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112197-112197
Closed Access | Times Cited: 53
Page 1 - Next Page

Scroll to top